Abstract
To investigate the mechanism causing cachexia and its association with shorter patient survival, we cloned weight‐loss‐inducing and ‐non‐inducing sublines of murine colon 26 carcinoma (colon 26). One clone, clone 20, induced substantial weight loss, wasting of adipose tissue and muscle, and hypogly‐cemia in mice with a minimum tumor burden of 0.3 g (2 g per 100 g body weight). Clone‐20‐bearing mice had a median survival of 24.5 days with average tumor weight of 0.4 g. In contrast, clone 5 induced neither severe weight loss, wasting of adipose tissue and muscle, nor hypoglycemia; clone‐5‐bearing mice survived for a median of 70 days with average tumor weight of 12 g. These results clearly indicate that shorter survival is associated with the degree of cachexia and is independent of tumor size. Using this pair of colon 26 clones, we examined mediators of cachexia. Neither TNFα, IL‐1α nor IFNγ was detected in the serum of mice bearing either clone, while IL‐6 was detected in mice bearing both clones by ELISA and a bioassay. Administration of anti‐IL‐6 monoclonal antibody (MAb) partially but significantly suppressed cachexia induction in clone‐20‐bearing mice. These results point to the involvement of IL‐6 in experimental cachexia. However, our finding of the presence of IL‐6 in the serum of mice bearing clone 5, which does not induce weight loss, clearly indicates that IL‐6 is not solely responsible for the induction of cachexia. © 1995 Wiley‐Liss, Inc.